Diabetes Rate Nearly Doubles; More Scrutiny of Avandia
The CDC came out with state-by-state estimates of diabetes rates yesterday, a watchdog group called for a ban on GlaxoSmithKline's diabetes drug Avandia, and the American Diabetes Association recommended against use of the drug.
No comments:
Post a Comment